Previous 10 | Next 10 |
Marrone Bio Innovations, Inc. (MBII) Q3 2019 Results Conference Call November 12, 2019 04:30 PM ET Company Participants Linda Moore - General Counsel Pam Marrone - CEO Jim Boyd - President and CFO Kevin Hammill - Chief Commercial Officer Conference Call Participants Samee...
Marrone Bio (NASDAQ: MBII ): Q3 GAAP EPS of -$0.14 misses by $0.09 . More news on: Marrone Bio Innovations, Inc., Earnings news and commentary, Energy stocks news, , Read more ...
Revenues Increased 46 Percent Year to Date to $22.7 Million; Increased 28 Percent in Third Quarter 2019 to $7.0 Million Gross Margins of 50+ Percent Achieved in Four Consecutive Quarters DAVIS, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NAS...
DAVIS, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced positive results for the 2019 field trials for its novel bioherbicide, known as MBI-015. ...
DAVIS, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, will release financial results for the third quarter ended September 30, 2019, after market close on Tuesday, Novemb...
DAVIS, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced that management has been invited to present at the MicroCap Rodeo Investment Conference in Austin, T...
DAVIS, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that its novel Bacillus Biofungicide, marketed in the U.S. as Stargus ® for specialty ...
DAVIS, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, announced today the closing of the previously announced acquisition of Finland-based Pro Farm Technologies OY ...
Marrone Bio Innovations ( MBII ) announces acquisition of all rights and assets to the Jet Ag and Jet Oxide product lines from Jet Harvest Solutions. The purchase price for the assets is ~$2.5M in cash, plus five yearly earn-out payments based on certain sales. More news on: Marrone Bio ...
DAVIS, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc . (NASDAQ: MBII), a leading developer of bio-based products for pest management and plant health, has acquired from Jet Harvest Solutions all rights and assets to the Jet Ag and Jet Oxide product lines. ...
News, Short Squeeze, Breakout and More Instantly...
Marrone Bio Innovations Inc. Company Name:
MBII Stock Symbol:
NASDAQ Market:
Marrone Bio Innovations Inc. Website:
ROTH MKM (“Roth”), a relationship-driven investment bank focused on serving growth companies and their investors, today announced that its agribusiness investment banking group has advised on three sellside transactions in the past nine months. According to the announcement, the tr...
RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved a proposal to adopt the previously announced Agreement and Plan of Merger (Merger Agreement...
RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022. Key results include: ...